InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Bryan Wahl, a General Counsel, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 17 open-market SEC Form 4 transactions: 0 purchases worth $0 and 17 sales worth $1.7M, reported from Nov 30, 22 to Mar 19, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 19, 26 | TARSTarsus Pharmaceuticals, Inc. | SELL | 4.2K | $67.00 | $283K |
| Mar 18, 26 | TARSTarsus Pharmaceuticals, Inc. | SELL | 4.1K | $68.71 | $283K |
| Mar 17, 26 | TARSTarsus Pharmaceuticals, Inc. | SELL | 4.1K | $69.42 | $284K |
| Mar 20, 25 | TARSTarsus Pharmaceuticals, Inc. | SELL | 3.1K | $50.11 | $155K |
| Mar 19, 25 | TARSTarsus Pharmaceuticals, Inc. | SELL | 3.3K | $47.40 | $155K |
| Mar 18, 25 | TARSTarsus Pharmaceuticals, Inc. | SELL | 3.3K | $46.29 | $155K |
| Mar 18, 24 | TARSTarsus Pharmaceuticals, Inc. | SELL | 4.4K | $30.60 | $136K |
| Nov 30, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 8.4K | $16.31 | $136K |
| Mar 23, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 371 | $12.15 | $5K |
| Mar 22, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 357 | $12.64 | $5K |
| Mar 21, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 350 | $12.89 | $5K |
| Mar 20, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 357 | $12.61 | $5K |
| Mar 17, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 339 | $13.28 | $5K |
| Mar 16, 23 | TARSTarsus Pharmaceuticals, Inc. | SELL | 337 | $13.43 | $5K |
| Dec 2, 22 | TARSTarsus Pharmaceuticals, Inc. | SELL | 1.2K | $16.90 | $20K |
| Dec 1, 22 | TARSTarsus Pharmaceuticals, Inc. | SELL | 1.2K | $16.75 | $19K |
| Nov 30, 22 | TARSTarsus Pharmaceuticals, Inc. | SELL | 1.2K | $16.50 | $20K |